Biograph VK10 vs Tempus ECG-Low EF

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Siemens Healthineers
VS
by Tempus

AI Verdict

The Biograph VK10 is a comprehensive PET/CT imaging system designed for broad disease detection and diagnosis across multiple specialties, including cardiology, by providing high-resolution anatomical and metabolic insights. In contrast, Tempus ECG-Low EF is an AI software focused specifically on analyzing ECGs to detect signs of low left ventricular ejection fraction, aiding in the identification of heart failure risk. While both tools contribute to cardiac care, they address different diagnostic needs with distinct technologies and deployment models.

Choose Biograph VK10 if…

Choose the Biograph VK10 if your clinical objective requires comprehensive, high-resolution anatomical and metabolic imaging for precise detection, diagnosis, and staging of complex diseases like cancer, cardiovascular conditions, or neurological disorders. This on-premise PET/CT system is ideal for detailed disease characterization and monitoring treatment response, offering both single modality and combined imaging capabilities.

View Biograph VK10 →

Choose Tempus ECG-Low EF if…

Choose Tempus ECG-Low EF if you need an efficient, AI-powered software solution to quickly screen and identify patients aged 40 or older who may be at risk of heart failure based on their 12-lead ECG recordings. This tool is best suited for integrating into existing clinical workflows to flag individuals with potential low left ventricular ejection fraction, prompting timely further diagnostic evaluation.

View Tempus ECG-Low EF →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Biograph VK10 Tempus ECG-Low EF
Deployment On-premise (integrated system) Integrates with current ECG platforms and electronic health records (EHRs).
FDA Status Cleared AI-estimated Cleared AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Tempus ECG-Low EF

Tempus ECG-Low EF, as AI software providing a binary output from standard ECGs, offers a simpler and more readily integrated user experience for a wider range of clinicians. Its software-based deployment and straightforward output are likely less complex to operate than a combined PET/CT scanner, which requires specialized training and operation.

Clinical Value

Biograph VK10

The Biograph VK10 provides comprehensive, high-resolution imaging for the detection, diagnosis, staging, and restaging of a wide array of critical conditions across oncology, cardiology, and neurology. While Tempus ECG-Low EF offers significant value for early heart failure detection, the breadth and depth of diagnostic information provided by a PET/CT scanner give it a broader clinical impact.

Pricing & Value

Tie

Tool A, a PET/CT scanner, represents a substantial capital investment, potentially ranging from hundreds of thousands to over a million dollars. Tool B is software with 'contact vendor' pricing, likely a subscription or per-use model, offering a lower entry barrier. Due to the vastly different nature and cost structures of these products, and the lack of specific pricing for Tool B, a direct comparison of 'value' is not feasible.

Enterprise Readiness

Tie

Both tools are FDA-cleared, HIPAA compliant, and offer Business Associate Agreements, demonstrating strong adherence to regulatory and data security standards essential for healthcare enterprises. Tool A benefits from Siemens' long-standing presence and infrastructure in hospitals, while Tool B is designed for seamless software integration into existing facility workflows, making both highly ready for enterprise adoption.

Innovation

Tempus ECG-Low EF

Tempus ECG-Low EF demonstrates a more disruptive innovation by leveraging AI to extract novel, clinically actionable insights from readily available ECG data for early heart failure risk detection. While Biograph VK10 offers significant advancements in imaging hardware and technology, Tempus's approach represents a paradigm shift in utilizing existing diagnostic tools for proactive screening at scale.

Support & Docs

Biograph VK10

Siemens, as a global leader in medical technology, provides a highly robust and extensive support and documentation ecosystem for its complex medical devices, including dedicated online portals, training academies, and comprehensive technical resources. Tempus AI, while a significant player in healthcare AI, does not publicly detail a comparable breadth of support infrastructure for its software.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Biograph VK10 Tempus ECG-Low EF
Name Biograph VK10 Tempus ECG-Low EF
Company Siemens Medical Solutions USA, Inc. Tempus AI
Description The Biograph VK10 is an FDA-cleared combined PET/CT scanner from Siemens Medical Solutions USA, Inc., providing high-resolution imaging for the detection and diagnosis of various diseases, including cancer, cardiovascular, and neurological conditions. Tempus ECG-Low EF is an FDA-cleared AI software that analyzes 12-lead ECG recordings to detect signs associated with low left ventricular ejection fraction (LVEF u226440%) in patients 40 years or older at risk of heart failure. It provides a binary output to aid clinicians in further evaluation.
Categories Cardiology AI, Neurology AI, Oncology AI Cardiology AI
Specialties Nuclear Medicine, Radiology Cardiology, Emergency Medicine, Internal Medicine
Key Features (Partial) Combined PET/CT imaging system, Air-cooled Silicon Photomultiplier (SiPM) PET system, Updated CT subsystem for high-resolution imaging AI-powered algorithm for ECG analysis, Detects signs of low Left Ventricular Ejection Fraction (LVEF u226440%), Analyzes resting, non-ambulatory 12-lead ECG recordings

Videos

Demos, reviews, and walkthroughs featuring Biograph VK10 and Tempus ECG-Low EF.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The Biograph VK10 is an FDA-cleared combined PET/CT imaging system designed for high-resolution detection and diagnosis of various diseases, including cancer, cardiovascular, and neurological conditions. Tempus ECG-Low EF is an FDA-cleared AI software that analyzes 12-lead ECG recordings to detect signs associated with low left ventricular ejection fraction (LVEF u226440%) in patients at risk of heart failure.
The Biograph VK10 is primarily intended for Nuclear Medicine and Radiology specialties, aiding in comprehensive imaging diagnostics. Tempus ECG-Low EF is intended for Cardiology, Emergency Medicine, and Internal Medicine, focusing on early identification of heart failure risk.
The Biograph VK10 provides high-resolution metabolic and anatomic images to aid in detecting, localizing, diagnosing, staging, and restaging diseases. Tempus ECG-Low EF provides a binary output (Low LVEF Detected / Not Detected) from ECG analysis to aid clinicians in further evaluating patients 40 years or older at risk of heart failure.
The Biograph VK10 utilizes data from combined PET and CT scans to generate detailed images for diagnostic purposes. Tempus ECG-Low EF analyzes resting, non-ambulatory 12-lead ECG recordings to identify specific cardiac indicators.
The Biograph VK10 aids in detecting and diagnosing a broad range of conditions, including cancer, cardiovascular, and neurological diseases through advanced imaging. Tempus ECG-Low EF specifically helps identify patients 40 years or older at risk of heart failure by detecting signs associated with low Left Ventricular Ejection Fraction (LVEF u226440%) from ECGs.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.